299 related articles for article (PubMed ID: 9102180)
21. Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.
Pownall HJ; Hu A; Gotto AM; Albers JJ; Sparrow JT
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3154-8. PubMed ID: 6774331
[TBL] [Abstract][Full Text] [Related]
22. Association of a model class A (apolipoprotein) amphipathic alpha helical peptide with lipid: high resolution NMR studies of peptide.lipid discoidal complexes.
Mishra VK; Anantharamaiah GM; Segrest JP; Palgunachari MN; Chaddha M; Sham SW; Krishna NR
J Biol Chem; 2006 Mar; 281(10):6511-9. PubMed ID: 16407255
[TBL] [Abstract][Full Text] [Related]
23. Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.
Roosbeek S; Vanloo B; Duverger N; Caster H; Breyne J; De Beun I; Patel H; Vandekerckhove J; Shoulders C; Rosseneu M; Peelman F
J Lipid Res; 2001 Jan; 42(1):31-40. PubMed ID: 11160363
[TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of free apolipoprotein-mediated cellular lipid efflux by probucol.
Tsujita M; Yokoyama S
Biochemistry; 1996 Oct; 35(40):13011-20. PubMed ID: 8855936
[TBL] [Abstract][Full Text] [Related]
25. Association of synthetic peptide fragments of human apolipoprotein A-I with phospholipids.
Vanloo B; Demoor L; Boutillon C; Lins L; Brasseur R; Baert J; Fruchart JC; Tartar A; Rosseneu M
J Lipid Res; 1995 Aug; 36(8):1686-96. PubMed ID: 7595090
[TBL] [Abstract][Full Text] [Related]
26. Composition and structural and functional properties of discoidal and spherical phospholipid-apoE3 complexes.
De Pauw M; Vanloo B; Dergunov AD; Devreese AM; Baert J; Brasseur R; Rosseneu M
Biochemistry (Mosc); 1997 Mar; 62(3):251-63. PubMed ID: 9275298
[TBL] [Abstract][Full Text] [Related]
27. Nuclear magnetic resonance investigation of the interactions with phospholipid of an amphipathic alpha-helix-forming peptide of the apolipoprotein class.
Lund-Katz S; Anantharamaiah GM; Venkatachalapathi YV; Segrest JP; Phillips MC
J Biol Chem; 1990 Jul; 265(21):12217-23. PubMed ID: 2373689
[TBL] [Abstract][Full Text] [Related]
28. Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.
Gorshkova IN; Mei X; Atkinson D
J Lipid Res; 2018 Feb; 59(2):348-356. PubMed ID: 29208698
[TBL] [Abstract][Full Text] [Related]
29. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux.
Daum U; Langer C; Duverger N; Emmanuel F; Benoit P; Denèfle P; Chirazi A; Cullen P; Pritchard PH; Bruckert E; Assmann G; von Eckardstein A
J Mol Med (Berl); 1999 Aug; 77(8):614-22. PubMed ID: 10543393
[TBL] [Abstract][Full Text] [Related]
31. The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation.
Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW; Landrum M
J Biol Chem; 1998 May; 273(19):11776-82. PubMed ID: 9565601
[TBL] [Abstract][Full Text] [Related]
32. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
Czarnecka H; Yokoyama S
Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein/lipid interactions: studies with synthetic polypeptides.
Sparrow JT; Gotto AM
CRC Crit Rev Biochem; 1982; 13(1):87-107. PubMed ID: 6813024
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of lipid-associating helices by use of three-dimensional molecular hydrophobicity potential calculations.
Brasseur R
J Biol Chem; 1991 Aug; 266(24):16120-7. PubMed ID: 1714906
[TBL] [Abstract][Full Text] [Related]
35. Probing structure and function of VLDL by synthetic amphipathic helical peptides.
Chung BH; Palgunachari MN; Mishra VK; Chang CH; Segrest JP; Anantharamaiah GM
J Lipid Res; 1996 May; 37(5):1099-112. PubMed ID: 8725161
[TBL] [Abstract][Full Text] [Related]
36. Systematic evaluation of lecithin:cholesterol acyltransferase binding sites in apolipoproteins via peptide based nanodiscs: regulatory role of charged residues at positions 4 and 7.
Niemelä A; Koivuniemi A
PLoS Comput Biol; 2024 May; 20(5):e1012137. PubMed ID: 38805510
[TBL] [Abstract][Full Text] [Related]
37. Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine.
Anantharamaiah GM; Jones JL; Brouillette CG; Schmidt CF; Chung BH; Hughes TA; Bhown AS; Segrest JP
J Biol Chem; 1985 Aug; 260(18):10248-55. PubMed ID: 4019510
[TBL] [Abstract][Full Text] [Related]
38. Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers.
Daum U; Leren TP; Langer C; Chirazi A; Cullen P; Pritchard PH; Assmann G; von Eckardstein A
J Lipid Res; 1999 Mar; 40(3):486-94. PubMed ID: 10064737
[TBL] [Abstract][Full Text] [Related]
39. Alteration in apolipoprotein A-I 22-mer repeat order results in a decrease in lecithin:cholesterol acyltransferase reactivity.
Sorci-Thomas MG; Curtiss L; Parks JS; Thomas MJ; Kearns MW
J Biol Chem; 1997 Mar; 272(11):7278-84. PubMed ID: 9054424
[TBL] [Abstract][Full Text] [Related]
40. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
Panzenböck U; Kritharides L; Raftery M; Rye KA; Stocker R
J Biol Chem; 2000 Jun; 275(26):19536-44. PubMed ID: 10751387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
